Status:
WITHDRAWN
Analysis Of Intracranial Artery Lesions Using 2-D/3D Phase Contrast MR
Lead Sponsor:
Lahey Clinic
Collaborating Sponsors:
VasSol®-Nova Software
Conditions:
Intracranial Arterial Aneurysm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Using phase contrast MR Angiography with NOVA® Software, this study intends to identify,evaluate and map intracranial aneurysm development as well as develope a predicator for future morphological cha...
Detailed Description
Hemodynamic stress toward the wall of intracranial artery with associated genuine defects of wall remodeling capacity is one of many hypotheses of subarachnoid aneurysm development. In addition, hemod...
Eligibility Criteria
Inclusion
- Unruptured and ruptured adult (\>18 years) intracranial arterial aneurysm patients
Exclusion
- Less than 18 years old
- Chronic renal failure patients
- Incompetent patient who cannot give consent for routine phase contrast MR Angiography and his/her surrogate decision maker is not available
- Any patients with a contraindication to having a standard MRI examination, such as phase maker, orbital metallic foreign body, etc.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00710281
Start Date
March 1 2008
End Date
December 1 2011
Last Update
September 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lahey Clinic, Inc.
Burlington, Massachusetts, United States, 01805